New uses warranted for cannabinoids? Recent data indicate that synthetic or endogenous substances activating the receptor for marijuana's psychotropic component might be used as templates for the development of new anti-cancer drugs.
This is a preview of subscription content, access via your institution
Relevant articles
Open Access articles citing this article.
-
A network-based pathway-expanding approach for pathway analysis
BMC Bioinformatics Open Access 23 December 2016
-
WIN55,212-2 induces cytoplasmic vacuolation in apoptosis-resistant MCL cells
Cell Death & Disease Open Access 03 November 2011
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
References
Adams, R. Marihuana. Harvey Lectures Ser. 37, 168–197 (1942).
Gaoni, Y. & Mechoulam R. Isolation, structure and partial synthesis of an active constituent of hashish. J. Amer. Chem. Soc. 86, 1646 (1964).
Pertwee, R.G. Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther. 74, 129–180 (1997).
Di Marzo, V. 'Endocannabinoids' and other fatty acid derivatives with cannabimimetic properties: Biochemistry and possible physiopathological relevance. Biochim. Biophys. Acta. 1392, 153–175 (1998).
Paria, B.C., Das, S.K. & Dey, S.K. The preimplantation mouse embryo is a target for cannabinoid ligand-receptor signaling. Proc. Natl. Acad. Sci. USA 92, 9460–9464 (1995).
Berrendero, F., Sepe, N., Ramos, J.A., Di Marzo, V. & Fernandez-Ruiz, J.J. Analysis of cannabinoid receptor binding and mRNA expression and endogenous cannabinoid contents in the developing rat brain during late gestation and early postnatal period. Synapse 33, 181–191 (1999).
Guzman, M., Sanchez, C. & Galve-Roperh, I. Control of the cell survival/death decision by cannabinoids. J. Mol. Med. 78, 613–625 (2001).
Munson, A.E., Harris, L.S., Friedman, M.A., Dewey, W.L. & Carchman, R.A. Antineoplastic activity of cannabinoids. J. Natl. Cancer Inst. 55, 597–602 (1975).
Tramer, M.R. et al. Cannabinoids for control of chemotherapy induced nausea and vomiting: Quantitative systematic review. Brit. Med. J. 323, 16–21 (2001).
Kinzbrunner, B.M. Review: Cannabinoids control chemotherapy-induced nausea and vomiting but increase the risk for side effects. ACP J. Club 136, 19 (2002).
Zhu, L.X. et al. Δ-9-tetrahydrocannabinol inhibits antitumor immunity by a CB2 receptor-mediated, cytokine-dependent pathway. J. Immunol. 165, 373–380 (2000).
Toxicology and carcinogenesis studies of 1-trans-Δ-9-tetrahydrocannabinol in F344N/N rats and BC63F1 mice. National Institutes of Health National Toxicology Program, NIH Publication No. 97-3362 (November 1996).
Watson, E.S. The effect of marijuana smoke exposure on murine sarcoma 180 survival in Fisher rats. Immunopharmacol. Immunotoxicol. 11, 211–222 (1989).
Barsky, S.H., Roth, M.D., Kleerup, E.C., Simmons, M. & Tashkin, D.P. Histopathologic and molecular alterations in bronchial epithelium in habitual smokers of marijuana, cocaine, and/or tobacco. J. Natl. Cancer Inst. 90, 1198–1205 (1998).
De Petrocellis, L. et al. The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation. Proc. Natl. Acad. Sci. USA 95, 8375–8380 (1998).
Melck, D. et al. Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation. Endocrinology 141, 118–126 (2000).
Sanchez, C., Galve-Roperh, I., Canova, C., Brachet, P. & Guzman, M. Δ9-tetrahydrocannabinol induces apoptosis in C6 glioma cells. FEBS Lett. 436, 6–10 (1998).
Ruiz, L., Miguel, A. & Diaz-Laviada, I. Δ9-tetrahydrocannabinol induces apoptosis in human prostate PC-3 cells via a receptor-independent mechanism. FEBS Lett. 458, 400–404 (1999).
Maccarrone, M., Lorenzon, T., Bari, M., Melino, G. & Finazzi-Agrò, A. Anandamide induces apoptosis in human cells via vanilloid receptors. Evidence for a protective role of cannabinoid receptors. J. Biol. Chem. 275, 31938–31945 (2000).
Jacobsson, S.O.P., Wallin, T. & Fowler, C.J. Inhibition of rat C6 glioma cell proliferation by endogenous and synthetic cannabinoids. Relative involvement of cannabinoid and vanilloid receptors. J. Pharmacol. Exp. Ther. 299, 951–959 (2001).
Galve-Roperh, I. et al. Anti-tumoral action of cannabinoids: Involvement of sustained ceramide accumulation and extracellular signal-regulated kinase activation. Nature Med. 6, 313–319 (2000).
Sanchez, C. et al. Inhibition of glioma growth in vivo by selective activation of the CB(2) cannabinoid receptor. Cancer. Res. 61, 5784–5789 (2001).
Bifulco, M. et al. Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth. FASEB J. 15, 2745–2747 (2001).
Pagotto, U. et al. Normal human pituitary gland and pituitary adenomas express cannabinoid receptor type 1 and synthesize endogenous cannabinoids: First evidence for a direct role of cannabinoids on hormone modulation at the human pituitary level. J. Clin. Endocrinol. Metab. 86, 2687–2696 (2001).
Maccarrone, M., Attina, M., Cartoni, A., Bari, M. & Finazzi-Agro, A. Gas chromatography-mass spectrometry analysis of endogenous cannabinoids in healthy and tumoral human brain and human cells in culture. J. Neurochem. 76, 594–601 (2001).
Melck, D. et al. Involvement of the cAMP/protein kinase A pathway and of mitogen-activated protein kinase in the anti-proliferative effects of anandamide in human breast cancer cells. FEBS Lett. 463, 235–240 (1999).
Hollister, L.E. Health aspects of cannabis: Revisited. Int. J. Neuropsychopharmacol. 1, 71–80 (1998).
Bisogno, T. et al. Biosynthesis and degradation of bioactive fatty acid amides in human breast cancer and rat pheochromocytoma cells—implications for cell proliferation and differentiation. Eur. J. Biochem. 254, 634–642 (1998).
Di Marzo, V. et al. Palmitoylethanolamide inhibits the expression of fatty acid amide hydrolase and enhances the anti-proliferative effect of anandamide in human breast cancer cells. Biochem. J. 358, 249–255 (2001).
Melck, D. et al. Unsaturated long-chain N-acyl-vanillyl-amides (N-AVAMs): Vanilloid receptor ligands that inhibit anandamide-facilitated transport and bind to CB1 cannabinoid receptors. Biochem. Biophys. Res. Commun. 262, 275–284 (1999).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Bifulco, M., Di Marzo, V. Targeting the endocannabinoid system in cancer therapy: A call for further research. Nat Med 8, 547–550 (2002). https://doi.org/10.1038/nm0602-547
Issue Date:
DOI: https://doi.org/10.1038/nm0602-547
This article is cited by
-
Cannabinoids orchestrate cross-talk between cancer cells and endothelial cells in colorectal cancer
Cancer Gene Therapy (2022)
-
Targeting the endocannabinoid system: a predictive, preventive, and personalized medicine-directed approach to the management of brain pathologies
EPMA Journal (2020)
-
The role of lipid signaling in the progression of malignant melanoma
Cancer and Metastasis Reviews (2018)
-
Cannabinoid-induced cell death in endometrial cancer cells: involvement of TRPV1 receptors in apoptosis
Journal of Physiology and Biochemistry (2018)
-
A network-based pathway-expanding approach for pathway analysis
BMC Bioinformatics (2016)